Addressing COVID-19 vaccine hesitancy. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Addressing COVID-19 vaccine hesitancy.

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Author Information

Rujittika Mungmunpuntipantip: Private Academic Consultant, Bangkok, Thailand.
Viroj Wiwanitkit: Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria.

PMID: 36121936 DOI: 10.1080/21645515.2022.2124090

No abstract text available.

Recenti Prog Med. 2021 Sep;112(9):596 [PMID: 34392326]
Hum Vaccin Immunother. 2022 Nov 30;18(5):2085471 [PMID: 35704781]
Asia Pac J Public Health. 2022 Sep;34(6-7):730 [PMID: 35815578]
Hum Vaccin Immunother. 2022 Nov 30;18(6):2107851 [PMID: 35993844]

Humans

COVID-19 Vaccines

COVID-19

Vaccination

COVID-19 Vaccines

Journal Article

Addressing COVID-19 vaccine hesitancy.Addressing COVID-19 Vaccine Hesitancy: The Role of Medical Students.COVID-19 vaccination in the UK: Addressing vaccine hesitancy.Addressing Vaccine Hesitancy in the Age of COVID-19.Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.Primary care physicians' strategies for addressing COVID-19 vaccine hesitancy.Addressing vaccine hesitancy and resistance for COVID-19 vaccines.Addressing COVID-19 vaccine hesitancy: is official communication the key?COVID-19 in Europe: new challenges for addressing vaccine hesitancy.Motivational Interviewing Strategies for Addressing COVID-19 Vaccine Hesitancy.

No available data.